Insider Trading & Ownership - Eterna Therapeutics Inc. (ERNA)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Eterna Therapeutics Inc.
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-12-02
Purchase
2022-12-06
9:02 pm
Eterna Therapeutics Inc.ERNACherington Charles
Director
10% Owner
261,756$3.28$858,5601,079,977
(Direct)
View
2022-12-02
Purchase
2022-12-06
6:52 pm
Eterna Therapeutics Inc.ERNASinger Nicholas Jason
Director
283,286$3.28$929,178832,786
(Indirect)
View
2022-12-02
Purchase
2022-12-05
6:05 pm
Eterna Therapeutics Inc.ERNAHALPERN JOHN D
10% Owner
335,920$3.28$1,101,8181,123,006
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-01
Option Award
2024-01-03
5:02 pm
N/A
2034-01-01
Eterna Therapeutics Inc.ERNALuther Sanjeev
President and CEO
1,685,218$01,685,218
(Direct)
View
2024-01-01
Option Award
2024-01-03
5:01 pm
N/A
2034-01-01
Eterna Therapeutics Inc.ERNAClarke Dorothy J
General Counsel
Director
168,521$0168,521
(Direct)
View
2023-12-14
Expired
2023-12-20
10:05 am
2023-07-14
2028-07-14
Eterna Therapeutics Inc.ERNACherington Charles
10% Owner
2,831,204$08,957,180
(Direct)
View
2023-12-14
Disposition
2023-12-18
9:38 pm
2023-06-02
2028-06-02
Eterna Therapeutics Inc.ERNAFreebird Partners LP
Freebird Investments LLC
HUFF CURTIS W
10% Owner
949,402$05,622,833
(Direct)
View
2023-12-14
Option Award
2023-12-18
9:38 pm
2023-06-02
2028-06-02
Eterna Therapeutics Inc.ERNAFreebird Partners LP
Freebird Investments LLC
HUFF CURTIS W
10% Owner
949,402$05,622,833
(Direct)
View
2023-06-21
Tax Withholding
2023-06-23
8:30 pm
N/A
N/A
Eterna Therapeutics Inc.ERNAGurrola Sandra M
Vice President of Finance
179$2.481,802
(Direct)
View
2023-06-21
Exercise
2023-06-23
8:30 pm
N/A
N/A
Eterna Therapeutics Inc.ERNAGurrola Sandra M
Vice President of Finance
438$01,802
(Direct)
View

Ownership
2023-04-04
5:03 pm
N/A
N/A
Eterna Therapeutics Inc.ERNAFreebird Partners LP
Freebird Investments LLC
HUFF CURTIS W
10% Owner
0$0697,510
(Direct)
View

Ownership
2023-03-06
4:01 pm
N/A
N/A
Eterna Therapeutics Inc.ERNADENNY GEORGE P III
10% Owner
0$0460,413
(Indirect)
View
2023-01-12
Option Award
2023-01-13
7:30 pm
N/A
2033-01-12
Eterna Therapeutics Inc.ERNAAngel Matthew
President and CEO
132,003$0132,003
(Direct)
View
2022-09-20
Exercise
2022-09-21
7:00 pm
N/A
N/A
Brooklyn ImmunoTherapeutics Inc.BTXSidhu Roger
Chief Medical Officer
20,163$080,650
(Direct)
View
2022-08-01
Option Award
2022-08-03
8:01 pm
N/A
2032-08-01
Brooklyn ImmunoTherapeutics Inc.BTXAngel Matthew
Interim President and CEO
2,487,003$02,487,003
(Direct)
View
2022-08-01
Option Award
2022-08-03
8:01 pm
N/A
2032-08-01
Brooklyn ImmunoTherapeutics Inc.BTXCherington Charles
Director
380,900$0380,900
(Direct)
View
2022-08-01
Option Award
2022-08-03
8:01 pm
N/A
2032-08-01
Brooklyn ImmunoTherapeutics Inc.BTXFiore Gregory
Director
260,900$0260,900
(Direct)
View
2022-08-01
Option Award
2022-08-03
8:01 pm
N/A
2032-08-01
Brooklyn ImmunoTherapeutics Inc.BTXWexler William A.
Director
317,900$0317,900
(Direct)
View
2022-08-01
Option Award
2022-08-03
8:01 pm
N/A
2032-08-01
Brooklyn ImmunoTherapeutics Inc.BTXSinger Nicholas Jason
Director
311,900$0311,900
(Direct)
View
2022-06-28
Tax Withholding
2022-06-29
8:01 pm
N/A
N/A
Brooklyn ImmunoTherapeutics Inc.BTXDAmour Kevin
Chief Scientific Officer
6,077$0.553464,213
(Direct)
View
2022-06-28
Exercise
2022-06-29
8:01 pm
N/A
N/A
Brooklyn ImmunoTherapeutics Inc.BTXDAmour Kevin
Chief Scientific Officer
17,573$064,213
(Direct)
View
2022-06-21
Tax Withholding
2022-06-23
8:31 pm
N/A
N/A
Brooklyn ImmunoTherapeutics Inc.BTXGurrola Sandra M
Vice President of Finance
3,586$0.476539,617
(Direct)
View
2022-06-21
Exercise
2022-06-23
8:31 pm
N/A
N/A
Brooklyn ImmunoTherapeutics Inc.BTXGurrola Sandra M
Vice President of Finance
8,750$039,617
(Direct)
View

Ownership
2022-06-07
9:08 pm
N/A
N/A
Brooklyn ImmunoTherapeutics Inc.BTXSinger Nicholas Jason
Director
0$02,095,000
(Indirect)
View
2022-06-03
Option Award
2022-06-06
5:01 pm
N/A
2032-06-03
Brooklyn ImmunoTherapeutics Inc.BTXJackson Andrew C.
Chief Financial Officer
664,800$0664,800
(Direct)
View

Ownership
2022-06-01
5:00 pm
N/A
N/A
Brooklyn ImmunoTherapeutics Inc.BTXAngel Matthew
Interim President and CEO
0$03,489,666
(Direct)
View
2022-03-11
Option Award(A)
2022-03-17
9:00 pm
N/A
2032-03-11
Brooklyn ImmunoTherapeutics Inc.BTXDAmour Kevin
Chief Scientific Officer
138,400$0138,400
(Direct)
View
2022-03-11
Option Award(A)
2022-03-17
9:00 pm
N/A
2032-03-11
Brooklyn ImmunoTherapeutics Inc.BTXGurrola Sandra M
Vice President of Finance
114,500$0114,500
(Direct)
View
2022-03-11
Option Award(A)
2022-03-17
9:00 pm
N/A
2032-03-11
Brooklyn ImmunoTherapeutics Inc.BTXFederoff Howard J.
CEO & President
413,700$0413,700
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, 3, 4, Next